PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'NuLease Medical Solutions, LLC, Louisville, KY, United States of America. Electronic address: rick@cales.com.\', \'NuLease Medical Solutions, LLC, Louisville, KY, United States of America. Electronic address: shannonc@nulease.com.\', \'University of Louisville, Department of Emergency Medicine, United States of America. Electronic address: jacob.shreffler@louisville.edu.\', \'University of Louisville, Department of Emergency Medicine, United States of America. Electronic address: martin.huecker@louisville.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0740-5472(21)00269-510.1016/j.jsat.2021.108543
?:doi
?:hasPublicationType
?:journal
  • Journal of substance abuse treatment
is ?:pmid of
?:pmid
?:pmid
  • 34210567
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.311
?:rankingScore_hIndex
  • 91
is ?:relation_isRelatedTo_publication of
?:title
  • The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34210567>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34210567>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all